Never Run Out Of Buyers To Sell To.

3D BioOptima strives to best serve our clients with value-added solutions for their drug R&D programs of chemical and biological therapeutics by conducting specialized preclinical services, such as absorption, distribution, metabolism and excretion (ADME) characterization, pharmacokinetic and pharmacodynamic evaluation, bioanalysis, high-throughput ADME screening, ADME-assisted lead optimization, biological/pharmacological screening, large molecule research, exploratory toxicity assessment, and regulatory consultation.
Annual Revenue$50M to $100M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.